Today's Daily Dose brings you news about Applied Therapeutics' ACTION-Galactosemia trial results, FDA approval of Merck's Keytruda for yet another indication, Verastem's a global licensing agreement with Chugai Pharma and SCYNEXIS' FURI study results.
from RTT - Biotech https://ift.tt/2TchMU9
via IFTTT
No comments:
Post a Comment